Form 8-K - Current report:
SEC Accession No. 0001213900-25-073670
Filing Date
2025-08-08
Accepted
2025-08-08 16:15:32
Documents
12
Period of Report
2025-08-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea025248301-8k_aditxt.htm   iXBRL 8-K 34731
  Complete submission text file 0001213900-25-073670.txt   205152

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE adtx-20250807.xsd EX-101.SCH 3017
3 XBRL LABEL FILE adtx-20250807_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE adtx-20250807_pre.xml EX-101.PRE 22360
14 EXTRACTED XBRL INSTANCE DOCUMENT ea025248301-8k_aditxt_htm.xml XML 3786
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

EIN.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39336 | Film No.: 251198608
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)